149 related articles for article (PubMed ID: 37000854)
1. Prognosis prediction of uterine cervical cancer using changes in the histogram and texture features of apparent diffusion coefficient during definitive chemoradiotherapy.
Takada A; Yokota H; Nemoto MW; Horikoshi T; Matsumoto K; Habu Y; Usui H; Nasu K; Shozu M; Uno T
PLoS One; 2023; 18(3):e0282710. PubMed ID: 37000854
[TBL] [Abstract][Full Text] [Related]
2. Association between MRI histogram features and treatment response in locally advanced cervical cancer treated by chemoradiotherapy.
Perucho JAU; Wang M; Tse KY; Ip PPC; Siu SWK; Ngan HYS; Khong PL; Lee EYP
Eur Radiol; 2021 Mar; 31(3):1727-1735. PubMed ID: 32885298
[TBL] [Abstract][Full Text] [Related]
3. Apparent diffusion coefficient histogram shape analysis for monitoring early response in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy.
Meng J; Zhu L; Zhu L; Wang H; Liu S; Yan J; Liu B; Guan Y; Ge Y; He J; Zhou Z; Yang X
Radiat Oncol; 2016 Oct; 11(1):141. PubMed ID: 27770816
[TBL] [Abstract][Full Text] [Related]
4. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
[TBL] [Abstract][Full Text] [Related]
5. Predicting tumor recurrence in patients with cervical carcinoma treated with definitive chemoradiotherapy: value of quantitative histogram analysis on diffusion-weighted MR images.
Erbay G; Onal C; Karadeli E; Guler OC; Arica S; Koc Z
Acta Radiol; 2017 Apr; 58(4):481-488. PubMed ID: 27445314
[TBL] [Abstract][Full Text] [Related]
6. Potentialities of multi-b-values diffusion-weighted imaging for predicting efficacy of concurrent chemoradiotherapy in cervical cancer patients.
Liu B; Ma WL; Zhang GW; Sun Z; Wei MQ; Hou WH; Hou BX; Wei LC; Huan Y
BMC Med Imaging; 2020 Aug; 20(1):97. PubMed ID: 32799809
[TBL] [Abstract][Full Text] [Related]
7. Histogram analysis of apparent diffusion coefficient for monitoring early response in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy.
Meng J; Zhu L; Zhu L; Ge Y; He J; Zhou Z; Yang X
Acta Radiol; 2017 Nov; 58(11):1400-1408. PubMed ID: 28273745
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging features of tumor and lymph node to predict clinical outcome in node-positive cervical cancer: a retrospective analysis.
Park SH; Hahm MH; Bae BK; Chong GO; Jeong SY; Na S; Jeong S; Kim JC
Radiat Oncol; 2020 Apr; 15(1):86. PubMed ID: 32312283
[TBL] [Abstract][Full Text] [Related]
9. Treatment response evaluation using the mean apparent diffusion coefficient in cervical cancer patients treated with definitive chemoradiotherapy.
Onal C; Erbay G; Guler OC
J Magn Reson Imaging; 2016 Oct; 44(4):1010-9. PubMed ID: 26919800
[TBL] [Abstract][Full Text] [Related]
10. Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy.
Lin G; Yang LY; Lin YC; Huang YT; Liu FY; Wang CC; Lu HY; Chiang HJ; Chen YR; Wu RC; Ng KK; Hong JH; Yen TC; Lai CH
Eur Radiol; 2019 Feb; 29(2):556-565. PubMed ID: 30051142
[TBL] [Abstract][Full Text] [Related]
11. The diffusion-weighted magnetic resonance imaging (DWI) predicts the early response of esophageal squamous cell carcinoma to concurrent chemoradiotherapy.
Wang L; Liu L; Han C; Liu S; Tian H; Li Z; Ren X; Shi G; Wang Q; Wang G
Radiother Oncol; 2016 Nov; 121(2):246-251. PubMed ID: 27838148
[TBL] [Abstract][Full Text] [Related]
12. Can diffusion-weighted magnetic resonance imaging predict tumor recurrence of uterine cervical cancer after concurrent chemoradiotherapy?
Bae JM; Kim CK; Park JJ; Park BK
Abdom Radiol (NY); 2016 Aug; 41(8):1604-10. PubMed ID: 27056747
[TBL] [Abstract][Full Text] [Related]
13. A multi-scanner study of MRI radiomics in uterine cervical cancer: prediction of in-field tumor control after definitive radiotherapy based on a machine learning method including peritumoral regions.
Takada A; Yokota H; Watanabe Nemoto M; Horikoshi T; Matsushima J; Uno T
Jpn J Radiol; 2020 Mar; 38(3):265-273. PubMed ID: 31907716
[TBL] [Abstract][Full Text] [Related]
14. Greater increases in intratumoral apparent diffusion coefficients after chemoradiotherapy predict better overall survival of patients with cervical cancer.
Holopainen E; Lahtinen O; Könönen M; Anttila M; Vanninen R; Lindgren A
PLoS One; 2023; 18(5):e0285786. PubMed ID: 37167301
[TBL] [Abstract][Full Text] [Related]
15. True progression versus pseudoprogression in the treatment of glioblastomas: a comparison study of normalized cerebral blood volume and apparent diffusion coefficient by histogram analysis.
Song YS; Choi SH; Park CK; Yi KS; Lee WJ; Yun TJ; Kim TM; Lee SH; Kim JH; Sohn CH; Park SH; Kim IH; Jahng GH; Chang KH
Korean J Radiol; 2013; 14(4):662-72. PubMed ID: 23901325
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted imaging: Apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer.
Choi MH; Oh SN; Rha SE; Choi JI; Lee SH; Jang HS; Kim JG; Grimm R; Son Y
J Magn Reson Imaging; 2016 Jul; 44(1):212-20. PubMed ID: 26666560
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of ADC quantification for clinical outcome in uterine cervical cancer treated with concurrent chemoradiotherapy.
Gu KW; Kim CK; Choi CH; Yoon YC; Park W
Eur Radiol; 2019 Nov; 29(11):6236-6244. PubMed ID: 30980126
[TBL] [Abstract][Full Text] [Related]
18. Prediction of early response to concurrent chemoradiotherapy in cervical cancer: Value of multi-parameter MRI combined with clinical prognostic factors.
Zheng X; Guo W; Dong J; Qian L
Magn Reson Imaging; 2020 Oct; 72():159-166. PubMed ID: 32621877
[TBL] [Abstract][Full Text] [Related]
19. Early treatment response of patients undergoing concurrent chemoradiotherapy for cervical cancer: An evaluation of integrated multi-parameter PET-IVIM MR.
Xu C; Sun H; Du S; Xin J
Eur J Radiol; 2019 Aug; 117():1-8. PubMed ID: 31307633
[TBL] [Abstract][Full Text] [Related]
20. Comparison of FDG PET metabolic tumour volume versus ADC histogram: prognostic value of tumour treatment response and survival in patients with locally advanced uterine cervical cancer.
Ueno Y; Lisbona R; Tamada T; Alaref A; Sugimura K; Reinhold C
Br J Radiol; 2017 Jul; 90(1075):20170035. PubMed ID: 28508679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
